Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biomedical Chromatography : BMC|October 8, 2022
Bioanalytical methods for pharmacokinetic studies of antileishmanial drugsIgnace C Roseboom, Hilde Rosing, Jos H Beijnen, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 3, 2020
Skin tissue sample collection, sample homogenization, and analyte extraction strategies for liquid chromatographic mass spectrometry quantification of pharmaceutical compoundsIgnace C Roseboom, Hilde Rosing, Jos H Beijnen, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 22, 2020
Highly sensitive UPLC-MS/MS method for the quantification of paromomycin in human plasmaIgnace C Roseboom, Bas Thijssen, Hilde Rosing, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 10, 2022
Development and validation of a high-performance liquid chromatography tandem mass spectrometry method for the quantification of the antiparasitic and antifungal drug amphotericin B in human skin tissueIgnace C Roseboom, Bas Thijssen, Hilde Rosing, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 11, 2021
Development and validation of an HPLC-MS/MS method for the quantification of the anti-leishmanial drug miltefosine in human skin tissueIgnace C Roseboom, Bas Thijssen, Hilde Rosing, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 11, 2022
Development and validation of an ultra-high performance liquid chromatography coupled to tandem mass spectrometry method for the quantification of the antileishmanial drug paromomycin in human skin tissueIgnace C Roseboom, Bas Thijssen, Hilde Rosing, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 24, 2024
Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method for the quantification of the antimalarial drug pyronaridine in human whole bloodWietse M Schouten, Ignace C Roseboom, Luc Lucas, et al.
Clinical Pharmacology and Therapeutics|November 25, 2025
Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal DosingWan-Yu Chu, Om Prakash Singh, Shyam Sundar, et al.
The Journal of Antimicrobial Chemotherapy|September 19, 2023
Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasisLuka Verrest, Ignace C Roseboom, Monique Wasunna, et al.
The Journal of Infectious Diseases|August 21, 2024
Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern AfricaWan-Yu Chu, Luka Verrest, Brima M Younis, et al.
Pageof 2